The transaction will give Medline access to treatments to manage patient fluid levels and contrast media and waste in diagnostic and interventional procedures.
Under the agreement, Medline will acquire AngioDynamics’ Namic brand, which consists of contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories.
Medline also will assume ownership of AngioDynamics’ manufacturing facility, including its sales and marketing team.
AngioDynamics is a supplier of minimally invasive medical devices for oncology, vascular access and peripheral vascular disease.
More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant ‘illness’ spur FDA safety review
5 supply chain technologies to watch
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
